Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
The heme detoxification pathway in *Plasmodium falciparum* is a critical biochemical process that enables the malaria parasite to survive within red blood cells. It involves the polymerization of toxic free heme, released during hemoglobin digestion, into inert hemozoin crystals within the digestive vacuole. This pathway is essential for parasite survival and is targeted by several antimalarial drugs, including chloroquine and artemisinin. Inhibiting this pathway leads to the accumulation of toxic heme and parasite death.
Inhibition of heme polymerization, leading to accumulation of toxic heme within the parasite's digestive vacuole.
3 more in the full profile.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Plasmodium falciparum Heme Detoxification Pathway.